论文部分内容阅读
目的:探讨全肺再切除术治疗耐多药肺结核的有效性和安全性。方法:选择我院2014年4月-2015年5月收治的54例耐多药肺结核患者,按照治疗方法不同分为两组。对照组患者行单纯西药治疗,观察组患者行全肺再切除术治疗。观察两组患者的治疗效果,并就两组患者不良反应发生率进行分析。结果:观察组患者治疗总有效率88.89%比较对照组77.78%显著升高,且观察组患者不良反应总发生率11.11%显著低于对照组22.22%,差异有统计学意义(P<0.05)。结论:针对耐多药肺结核患者行全肺再切除术的治疗效果较好,不但能快速清除患者病灶,降低治疗过程中的不良反应,且安全性更高,值得临床推广。
Objective: To investigate the effectiveness and safety of total lung resection in the treatment of multidrug-resistant pulmonary tuberculosis. Methods: 54 cases of MDR-TB patients admitted to our hospital from April 2014 to May 2015 were divided into two groups according to the different treatment methods. Patients in the control group were treated with pure western medicine, while patients in the observation group were treated with total lung resection. The therapeutic effect of two groups of patients was observed, and the incidence of adverse reactions in both groups was analyzed. Results: The total effective rate of observation group was 88.89% compared with 77.78% of control group, and the total incidence of adverse reactions in observation group was 11.11%, significantly lower than that of control group (22.22%, P <0.05). Conclusion: The treatment of multidrug - resistant pulmonary tuberculosis patients is better than the whole lung resection, which not only can quickly clear the lesion and reduce the adverse reactions during treatment, but also have higher safety and worthy of clinical promotion.